Indication intelligence, analysis and sector perception

Higher open expected; RegMed investors’ pre-open, cell therapy needs to grow up faster

June 20, 2016 6:33am

Beyond the turmoil, eight (8) down sessions out of ten (10) in the last two (2) weeks doesn’t speak well of sustainability

… Might make for a great movie – “The Kids”, which is only fitting, since its vision of arrogance involves managements showing up in the morning, whether inspired by their outsized pay checks and in spite of their own investors as their share pricing keeps falling!

I ask a special favor; find me some good news to write about!

Where do investors turn for honest/truthful insight and perspective - I say intelligently what others won't, so you can do what others can't!

Where is today’s market going – subscribe and find out?

Members only. Please login.

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

3 hours 56 min ago
RMi pre-open: A dose of roll-overs

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.